| （単位：千ドル） | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 10,692 | 11,910 | 12,523 | 16,009 | 27,054 | 17,627 | 22,826 | 17,989 | 19,453 | 29,883 | 29,109 | 33,226 | 30,624 |
| 営業費用 | 15,450 | 16,522 | 17,762 | 23,254 | 33,293 | 23,222 | 29,602 | 21,601 | 23,342 | 34,339 | 33,530 | 37,621 | 34,873 |
| 営業利益 | -15,450 | -16,522 | -17,762 | -23,254 | -33,293 | -23,222 | -29,602 | -21,601 | -23,342 | -34,339 | -33,530 | -37,621 | -34,873 |
| 純利益 | -15,339 | -16,406 | -17,713 | -23,030 | -32,858 | -22,720 | -28,286 | -20,095 | -21,502 | -30,970 | -30,382 | -34,555 | -30,389 |
| 一株あたり利益 | - | -0.42 | -0.45 | -0.58 | -0.82 | -0.57 | -0.7 | -0.49 | -0.48 | -0.56 | -0.54 | -0.6 | -0.36 |
| 希薄化後一株あたり利益 | - | -0.42 | -0.45 | -0.58 | -0.82 | -0.57 | -0.69 | -0.49 | -0.48 | -0.56 | -0.54 | -0.6 | -0.36 |
| EBITDA | - | - | - | - | - | - | - | - |